CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells
about
Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activationA modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeAlternative splicing of CARMA2/CARD14 transcripts generates protein variants with differential effect on NF-κB activation and endoplasmic reticulum stress-induced cell deathThe paracaspase MALT1: biological function and potential for therapeutic inhibitionOverexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progressionB-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation.Phosphorylation of Thr-516 and Ser-520 in the kinase activation loop of MEKK3 is required for lysophosphatidic acid-mediated optimal IkappaB kinase beta (IKKbeta)/nuclear factor-kappaB (NF-kappaB) activation.Protein phosphatase 2A acts as a mitogen-activated protein kinase kinase kinase 3 (MEKK3) phosphatase to inhibit lysophosphatidic acid-induced IkappaB kinase beta/nuclear factor-kappaB activation.The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation.The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli.The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis.AGTR1 as a therapeutic target in ER-positive and ERBB2-negative breast cancer cases.Lung fibroblasts from patients with idiopathic pulmonary fibrosis exhibit genome-wide differences in DNA methylation compared to fibroblasts from nonfibrotic lungT-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.Bcl10 mediates angiotensin II-induced cardiac damage and electrical remodeling.Linking angiotensin II to nuclear factor-κ light chain enhancer of activated B cells-induced cardiovascular damage: bad CARMAs.Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosomeCARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progressionCARMA3: A novel scaffold protein in regulation of NF-κB activation and diseasesAliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet.Proinflammatory protein CARD9 is essential for infiltration of monocytic fibroblast precursors and cardiac fibrosis caused by Angiotensin II infusion.MALT1-ubiquitination triggers non-genomic NF-κB/IKK signaling upon platelet activationUse of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitis.Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-κB activation following carrageenan.NF-κB signaling pathways regulated by CARMA family of scaffold proteins.The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.The Dishevelled, EGL-10 and pleckstrin (DEP) domain-containing protein DEPDC7 binds to CARMA2 and CARMA3 proteins, and regulates NF-κB activationInnate and Adaptive Immunity in Calcific Aortic Valve DiseaseCARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation.G Protein-Coupled Receptor and RhoA-Stimulated Transcriptional Responses: Links to Inflammation, Differentiation, and Cell Proliferation.Regulation of NF-κB by the CARD proteinsInternational Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth.BCL10GFP fusion protein as a substrate for analysis of determinants required for mucosa-associated lymphoid tissue 1 (MALT1)-mediated cleavage.Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury.The Paracaspase MALT1.Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation.Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.MEKK3 is required for lysophosphatidic acid-induced NF-kappaB activation.
P2860
Q24298225-43A55140-725F-4FF5-817C-8B910AD98678Q24306614-9B3498EF-B838-45A3-8AFB-47786173CC85Q24339441-317F7430-72AB-4C38-A416-B430A51521DAQ26778357-18D5404F-CAC2-4C0C-8485-A75765DD2197Q28483701-1C66FE86-517B-48D6-86E2-6220FA9CFC77Q33581388-4040A554-8C16-4B0D-9C0C-6C7D697F8A94Q33706949-1D2CD700-2F83-4371-A164-9B4C4869F3AEQ33967150-A1B35563-002F-404C-99F7-0BB4CF585E9DQ34030580-1196BBED-E308-4421-A2C0-4C18CE1CB860Q34070358-F1CE15F9-2B33-4125-924D-0011D2BFDFC7Q34074217-A629B34F-9798-4DF3-9431-730ACE3F8285Q34133185-4C811C90-9B3C-4DE0-8728-0B3EDF5176CDQ34172455-A389EA5B-A324-4986-A3DA-FBC86A169395Q34174201-0349BA9E-D0F4-4A33-9BB5-3CCE9070704EQ34315544-6685C667-BD35-4292-AD29-844DC6015335Q34315999-CA8CB913-177D-4E67-A58E-7EF977CBE2D0Q34438768-DFDB5E41-B33B-46CF-BE6E-DD0725F768D5Q34691397-E85197FB-A757-4BB6-BA91-82F37DCFBFA3Q34878582-2487AB63-70A4-40EC-BBE4-B3AF7DB3F228Q35035662-1D31E0E8-83D6-46D8-A888-94C31E322B21Q35114753-F908AA89-10FB-43DF-B5F5-5076EF15BE12Q35154856-48EE2BB6-94D4-420C-9395-34170A03DF1BQ35184531-84DBA894-53C3-4A57-89AA-FF06894DFEECQ35216729-81396B26-D19B-4F9A-A385-0BEC043947A5Q35347919-19B18E11-8040-4824-BE20-229271FF45CBQ35423381-E8C1B870-3074-44B1-AD92-FFDDAF4AA343Q35534352-A2F2BDD7-5CB5-47F3-81A0-9DE0AD27127DQ35612638-2EF19141-852D-474B-ADFD-65AB6E2E6F28Q35741899-7DC0E8A0-316A-404A-8268-5B6931A96931Q35745964-F1CF9CBF-38CD-4F69-9075-078F9EB686B4Q35920998-093C4643-7ADE-4E33-AB6F-BC645C3F7927Q36241932-11E4398B-B654-4661-9D80-FB6BD54B0CE9Q36395591-8885AC34-7E62-4396-996C-9283315494C8Q36406611-4998A2E9-EE3E-4D5F-AAF7-21DEB980977EQ36516285-4EC63A68-301E-4340-B0F0-ACCEAC090E8AQ36563807-1AB05C09-55D6-4A7A-B47F-DFFBC9B71335Q36804966-8B76A0BA-D85D-4261-8653-90F782ADAFDBQ36964334-3CC9B925-DBBB-4E25-BC41-04B9E9BDC895Q36973638-C004CB43-BEC9-4C46-B6D6-468B87707CF6Q37284987-5BF403BD-6B99-4245-82E5-F2A091B3263D
P2860
CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
CARMA3/Bcl10/MALT1-dependent N ...... y signaling in nonimmune cells
@ast
CARMA3/Bcl10/MALT1-dependent N ...... y signaling in nonimmune cells
@en
CARMA3/Bcl10/MALT1-dependent N ...... y signaling in nonimmune cells
@nl
type
label
CARMA3/Bcl10/MALT1-dependent N ...... y signaling in nonimmune cells
@ast
CARMA3/Bcl10/MALT1-dependent N ...... y signaling in nonimmune cells
@en
CARMA3/Bcl10/MALT1-dependent N ...... y signaling in nonimmune cells
@nl
prefLabel
CARMA3/Bcl10/MALT1-dependent N ...... y signaling in nonimmune cells
@ast
CARMA3/Bcl10/MALT1-dependent N ...... y signaling in nonimmune cells
@en
CARMA3/Bcl10/MALT1-dependent N ...... y signaling in nonimmune cells
@nl
P2093
P2860
P356
P1476
CARMA3/Bcl10/MALT1-dependent N ...... y signaling in nonimmune cells
@en
P2093
David S L Kim
Dawn Kohrt
Gabriel Nuñez
Linda M McAllister-Lucas
Peter C Lucas
Peter Kuffa
Shufang Gu
Xiaohong Jin
P2860
P304
P356
10.1073/PNAS.0601947103
P407
P577
2007-01-02T00:00:00Z